R 172.00

Description: Gravi-C is a combination of selected herbs that work synergistically to relieve the symptoms and side-effects of cancer and HIV and to create a feeling of well-being.
Dosage: Take 2 capsules daily with your evening meal.
Contraindications: Do not exceed recommended dosages unless on the advice of a healthcare practitioner. Do not use this product if you are allergic to any of the ingredients. If you are pregnant, or on any medication or suffering from any medical condition it is advisable to seek medical advice before starting any new supplement. Store in a cool dry place, below 25°C and keep out of the reach of children.
Ingredients: Graviola Graviola has been shown to have an effect on cancer cells which can be of great benefit to someone who is fighting cancer. Nearly 25 years ago it was discovered that the leaf of the graviola tree contained natural compounds having exceptional cytotoxic activity. In other words, they had a very strong ability to prevent abnormal cellular division. In an 1976 plant screening program by the National Cancer Institute, the leaves and stem of Graviola showed active cytotoxicity against cancer cells and researchers have been following up on this research ever since. Much of the research on Graviola focuses on a novel set of phytochemicals called annonaceous acetogenins. The potent antitumor properties of these annonaceous acetogenins have been reported and patented. Graviola produces these natural compounds in leaf, bark and twig tissues, and have been documented to possess both highly anti-tumor and anti-pesticidal properties. Three separate research groups have isolated novel compounds in the seeds and leaves of Graviola which have demonstrated significant anti-tumorous, anticancerous and selective toxicity against various types of cancer cells, publishing 8 clinical studies on their findings. One study demonstrated that an acetogenin in Graviola was selectively cytotoxic to colon adenocarcinoma cells in which it was 10,000 times the potency of adriamycin (a chemotherapy drug). Cancer research is ongoing on Graviola, and four new studies have been published in 1998 which further narrow down the specific phytochemicals which are demonstrating the strongest anticancerous and antiviral properties. In 1997, Purdue University published information with promising news that Graviola: 'not only is effective in killing tumors that have proven resistant to anti-cancer agents, but also seem to have a special affinity for these drug resistant cells.' Magnolol Magnolol, a substance taken from the root and bark of the magnolia tree, is a potent killer of prostate cancer cells, according to a study in the Journal of Cellular Biochemistry. Because it does not damage healthy cells, magnolol could be a promising new therapy for prostate cancer, as well as other types of cancers. Magnolol, a compound isolated from the root and bark of the magnolia tree, has been used in China and Japan for thousands of years to treat a variety of conditions, ranging from inflammation to ulcers. Recent research suggests that it also slows the growth and triggers the death of cancer cells. Researchers at the University of Pittsburgh wanted to learn how effectively magnolol kills cancer cells, and how exactly it triggers cancer cell death. When they treated several different types of human prostate cancer cells with magnolol for 24 hours, they found that the compound both decreased the number of cancer cells, and changed their shape in a way that suggested the cells were undergoing apoptosis (cell death). The treatment worked on many different types of prostate cancer cells, regardless of their invasiveness. The higher the dose of magnolol, the more significant the damage it caused to cancer cells. Meanwhile, magnolol treatment did not appear to harm healthy prostate cells. The researchers then took their investigation a step further, looking at the pathways by which magnolol affected prostate cancer cells. “It is very important to understand how magnolol acts as an anticancer agent,” says lead author Yong Lee, PhD, Professor in the Department of Surgery and Pharmacology at the University of Pittsburgh. “If we understand the mechanisms of killing (pathways, model of death, etc.), we can improve the efficacy of the drug and avoid side effects.” Dr. Lee’s team discovered that magnolol alters the activity of various proteins that are involved in the apoptosis process, in order to promote cancer cell death. It also inhibits growth factor receptors that are typically produced in larger-than-normal amounts by cancer cells to help those cells survive. Its ability to destroy cancer cells without harming healthy cells makes magnolol a promising treatment strategy. Although this study focused on prostate cancer, the treatment may also be useful for other types of cancers.

Disclaimer: All information contained on this website is for information only and should not be used to diagnose, prevent, treat or cure any disease, health or medical condition. The products (food supplements) are not intended to diagnose, prevent, treat or cure any health or medical condition. Do not exceed recommended dosages unless on the advice of a healthcare practitioner. Do not use this product if you are allergic to any of the ingredients. If you are pregnant, or on any medication or suffering from any medical condition it is advisable to seek medical advice before starting any new supplement. Store in a cool dry place, below 25°C and keep out of the reach of children.